Evaluation of oxindole derivatives as a potential anticancer agent against breast carcinoma cells: In vitro, in silico, and molecular docking study

S Puri, I Ahmad, H Patel, K Kumar, K Juvale - Toxicology in Vitro, 2023 - Elsevier
In this study we have performed the in vitro anticancer activity of spiro oxindole derivatives
against MCF-7 (human Adreno carcinoma) and MDA-MB-231 (triple negative breast cancer) …
被引用次数：23 相关文章

Evaluation of oxindole derivatives as a potential anticancer agent against breast carcinoma cells: In vitro, in silico, and molecular docking study

S Puri, I Ahmad, H Patel, K Kumar… - Toxicology in vitro: an …, 2023 - pubmed.ncbi.nlm.nih.gov
In this study we have performed the in vitro anticancer activity of spiro oxindole derivatives
against MCF-7 (human Adreno carcinoma) and MDA-MB-231 (triple negative breast cancer) …

Evaluation of oxindole derivatives as a potential anticancer agent against breast carcinoma cells: In vitro, in silico, and molecular docking study.

S Puri, I Ahmad, H Patel, K Kumar… - Toxicology in Vitro: an …, 2022 - europepmc.org
In this study we have performed the in vitro anticancer activity of spiro oxindole derivatives
against MCF-7 (human Adreno carcinoma) and MDA-MB-231 (triple negative breast cancer) …

Evaluation of oxindole derivatives as a potential anticancer agent against breast carcinoma cells: In vitro, in silico, and molecular docking study

S Puri, I Ahmad, H Patel, K Kumar… - Toxicology in …, 2023 - ui.adsabs.harvard.edu
In this study we have performed the in vitro anticancer activity of spiro oxindole derivatives
against MCF-7 (human Adreno carcinoma) and MDA-MB-231 (triple negative breast cancer) …